SLAM Polyclonal Antibody

High-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.

The SLAM Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Signaling Lymphocytic Activation Molecule (SLAM) protein. This antibody is produced using advanced techniques and rigorous quality control measures to ensure optimal performance and reproducibility.

The SLAM Polyclonal Antibody exhibits exceptional sensitivity and specificity, making it an ideal choice for various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It recognizes the SLAM protein in a wide range of species, including human, mouse, and rat, enabling versatile experimental designs.

With its superior performance characteristics, the SLAM Polyclonal Antibody offers researchers a valuable tool for investigating the role of SLAM in various biological processes and disease states. Its high affinity and selectivity allow for precise and accurate detection of SLAM protein expression levels, facilitating in-depth studies and reliable data interpretation.

Furthermore, the SLAM Polyclonal Antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reproducibility. Each lot is thoroughly tested to meet the highest standards of quality, purity, and specificity, guaranteeing reliable and consistent results.

In summary, the SLAM Polyclonal Antibody is a highly reliable and specific tool for the detection and analysis of SLAM protein. Its exceptional sensitivity, versatility, and stringent quality control measures make it an indispensable asset for researchers in the field of immunology and beyond.